Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
GPCR Desensitization
Heart Failure Drugs: Diuretics
Cardiomyopathy II: Dilated Cardiomyopathy
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Wenjing Yu1,2, Zhen Guo1,2, Huimin Liang1
1National and Local United Engineering Laboratory of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangdong Province Engineering Laboratory for Druggability and New Drug Evaluation, School of Pharmaceutical Sciences (W.Y., Z.G., H.L., D.M., C.L., Z. Li, J.Y., P.L., J.L.), Sun Yat-sen University, Guangzhou, China.
葡萄糖酸氨基醇特异性脂酶D1 (GPLD1) 通过维持细胞平衡和线粒体功能来防止心力衰竭 (HF). 泌尿酸酶类型的等离子体激活剂受体 (uPAR) 相互作用是GPLD1在心脏功能障碍中的保护作用的关键.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: